Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease

CompletedOBSERVATIONAL
Enrollment

781

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2008

Conditions
Keratoconjunctivitis Sicca
Interventions
DRUG

cyclosporine ophthalmic emulsion 0.05%, artificial tears

one drop, twice a day in each eye

Trial Locations (1)

Unknown

Wilson

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT00717418 - Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease | Biotech Hunter | Biotech Hunter